A detailed history of Core Alternative Capital transactions in Medtronic PLC stock. As of the latest transaction made, Core Alternative Capital holds 41,824 shares of MDT stock, worth $3.77 Million. This represents 0.68% of its overall portfolio holdings.

Number of Shares
41,824
Previous 38,993 7.26%
Holding current value
$3.77 Million
Previous $3.4 Million 3.15%
% of portfolio
0.68%
Previous 0.61%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 16, 2024

BUY
$78.71 - $87.02 $222,828 - $246,353
2,831 Added 7.26%
41,824 $3.29 Million
Q1 2024

May 15, 2024

BUY
$82.84 - $88.09 $277,348 - $294,925
3,348 Added 9.39%
38,993 $3.4 Million
Q4 2023

Feb 14, 2024

SELL
$69.43 - $83.43 $293,688 - $352,908
-4,230 Reduced 10.61%
35,645 $2.94 Million
Q3 2023

Oct 19, 2023

BUY
$78.22 - $90.4 $146,584 - $169,409
1,874 Added 4.93%
39,875 $3.12 Million
Q2 2023

Jul 27, 2023

BUY
$79.47 - $91.38 $121,350 - $139,537
1,527 Added 4.19%
38,001 $3.35 Million
Q1 2023

Apr 18, 2023

BUY
$76.72 - $87.58 $1.89 Million - $2.16 Million
24,667 Added 208.92%
36,474 $2.94 Million
Q4 2022

Jan 31, 2023

SELL
$76.18 - $87.74 $397,735 - $458,090
-5,221 Reduced 30.66%
11,807 $917,000
Q3 2022

Oct 18, 2022

BUY
$80.75 - $95.31 $314,925 - $371,709
3,900 Added 29.71%
17,028 $1.38 Million
Q2 2022

Aug 01, 2022

BUY
$87.4 - $113.09 $613,897 - $794,344
7,024 Added 115.07%
13,128 $1.18 Million
Q1 2022

May 10, 2022

BUY
$100.58 - $112.38 $502,397 - $561,338
4,995 Added 450.41%
6,104 $677,000
Q4 2021

Feb 11, 2022

BUY
$99.53 - $127.75 $91,766 - $117,785
922 Added 493.05%
1,109 $115,000
Q3 2021

Nov 05, 2021

BUY
$122.75 - $135.17 $22,954 - $25,276
187 New
187 $23,000

Others Institutions Holding MDT

About Medtronic plc


  • Ticker MDT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,329,149,952
  • Market Cap $120B
  • Description
  • Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...
More about MDT
Track This Portfolio

Track Core Alternative Capital Portfolio

Follow Core Alternative Capital and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Core Alternative Capital, based on Form 13F filings with the SEC.

News

Stay updated on Core Alternative Capital with notifications on news.